Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-22T08:18:28.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 01 18 has been updated to 05 08 on the webpage, indicating a recent change in the information related to Medical and healthcare-related publications and documentation.
    Difference
    0.6%
    Check dated 2024-05-09T01:54:38.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:35:30.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.